THE MOUSE MODEL IN TBI
References
Caravan, P., Ellison, J. J., McMurry, T. J., & Lauffer, R. B. (1999). Gadolinium (III) chelates as
MRI contrast agents: structure, dynamics, and applications. Chemical reviews, 99(9), 2293-2352.
Gambhir, S. S. (2002). Molecular imaging of cancer with positron emission tomography. Nature
reviews. Cancer, 2(9), 683.
Jarritt, P. H., & Acton, P. D. (1996). PET imaging using gamma camera systems: A review.
Nuclear medicine communications, 17(9), 758-766.
Kim, B., Semelka, R. C., Ascher, S. M., Chalpin, D. B., Carroll, P. R., & Hricak, H. (1994).
Bladder tumor staging: comparison of contrast-enhanced CT, T1-and T2-weighted MR imaging,
dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology,
193(1), 239-245.
Kosior, R. K., Kosior, J. C., & Frayne, R. (2007). Improved dynamic susceptibility contrast
(DSC)‐MR perfusion estimates by motion correction. Journal of Magnetic Resonance Imaging,
26(4), 1167-1172.
Schlemmer, H. P., Pichler, B. J., Krieg, R., & Heiss, W. D. (2009). An integrated MR/PET
system: prospective applications. Abdominal imaging, 34(6), 668.